Bioabsorbable coronary stents.
Ormiston
John A
JA
Mercy Angiography, Mercy Hospital, Auckland, New Zealand. johno@mercyangiography.co.nz
Serruys
Patrick W S
PW
D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D019344:Lactic Acid; D008274:Magnesium; D011076:Polycarboxylate Cement; D011091:Polyesters; D011108:Polymers; D011474:Prosthesis Design; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D015607:Stents; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D011076:Polycarboxylate Cement; D011091:Polyesters; D011108:Polymers; C005506:polycarbonate; D019344:Lactic Acid; C033616:poly(lactide); D000068338:Everolimus; D008274:Magnesium; D020123:Sirolimus